Clinical Trial Update: Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating toripalimab in combination with standard treatment for HPV-positive oropharyngeal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: University of Chicago | Conditions: Oropharyngeal Cancer | Phase 2 | Status: RECRUITING